日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細


公開

学術論文

Ceftriaxone-resistant Salmonella enterica serotype Newport, France

MPS-Authors
/persons/resource/persons82133

Sangal,  Vartul
Max-Planck Research Group RNA Biology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons81778

Achtman,  Mark
Department of Molecular Biology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource
There are no locators available
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)

Emerg_inf_dis_2008_14_954.pdf
(出版社版), 324KB

付随資料 (公開)
There is no public supplementary material available
引用

Egorova, S., Timinouni, M., Demartin, M., Granier, S. A., Whichard, J. M., Sangal, V., Fabre, L., Delaune, A., Pardos, M., Millemann, Y., Espie, E., Achtman, M., Grimont, P. A. D., & Weill, F.-X. (2008). Ceftriaxone-resistant Salmonella enterica serotype Newport, France. Emerging Infectious Diseases, 14(6), 954-957.


引用: https://hdl.handle.net/11858/00-001M-0000-000E-C1BA-B
要旨
The multidrug-resistant (MDR) Salmonella enterica serotype Newport strain that produces CMY-2 β-lactamase(Newport MDR-AmpC) was the source of sporadic cases and outbreaks in humans in France during 2000–2005. Because this strain was not detected in food animals, it was most likely introduced into France through imported food products.